A negative effect of Campylobacter capsule on bacterial interaction with an analogue of a host cell receptor

por Rubinchik, Sona, Seddon, Alan M, Karlyshev, Andrey V
Publicado 2014

Potential probiotic-associated traits revealed from completed high quality genome sequence of Lactobacillus fermentum 3872

por Lehri, Burhan, Seddon, Alan M., Karlyshev, Andrey V.
Publicado en Stand Genomic Sci (2017)

Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule t...

por Puvanenthiran, Soozana, Essapen, Sharadah, Seddon, Alan M., Modjtahedi, Helmout
Publicado en Int J Oncol (2016)

Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines

por Stanley, Aryan, Ashrafi, G. Hossein, Seddon, Alan M., Modjtahedi, Helmout
Publicado en Sci Rep (2017)

CmeABC Multidrug Efflux Pump Contributes to Antibiotic Resistance and Promotes Campylobacter jejuni Survival and Multiplication in Acanthamoeba polyphaga

por Vieira, Ana, Ramesh, Amritha, Seddon, Alan M., Karlyshev, Andrey V.
Publicado en Appl Environ Microbiol (2017)

Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cells

por Ioannou, Nikolaos, Seddon, Alan M, Dalgleish, Angus, Mackintosh, David, Modjtahedi, Helmout
Publicado 2013

Acquired resistance to anti-EGFR mAb ICR62 in cancer cells is accompanied by an increased EGFR expression, HER-2/HER-3 signalling and sensitivity to pan HER blockers

por Khelwatty, Said A, Essapen, Sharadah, Seddon, Alan M, Fan, Zhen, Modjtahedi, Helmout
Publicado en Br J Cancer (2015)

Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition

por IOANNOU, NIKOLAOS, SEDDON, ALAN M., DALGLEISH, ANGUS, MACKINTOSH, DAVID, SOLCA, FLAVIO, MODJTAHEDI, HELMOUT
Publicado en Int J Oncol (2016)

Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer

por Khelwatty, Said Abdullah, Essapen, Sharadah, Bagwan, Izhar, Green, Margaret, Seddon, Alan M., Modjtahedi, Helmout
Publicado en Oncotarget (2019)

HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with RAS Wild Type Metastatic Colorectal Cancer

por Khelwatty, Said A., Puvanenthiran, Soozana, Essapen, Sharadah, Bagwan, Izhar, Seddon, Alan M., Modjtahedi, Helmout
Publicado en Cancers (Basel) (2021)

Three-dimensional visualisation of developmental stages of an apicomplexan fish blood parasite in its invertebrate host

por Hayes, Polly M, Wertheim, David F, Smit, Nico J, Seddon, Alan M, Davies, Angela J
Publicado 2011

Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antag...

por Khan, Tanzeel, Seddon, Alan M., Dalgleish, Angus G., Khelwatty, Said, Ioannou, Nikolaos, Mudan, Satvinder, Modjtahedi, Helmout
Publicado en Oncol Rep (2020)

YPTB3816 of Yersinia pseudotuberculosis strain IP32953 is a virulence-related metallo-oligopeptidase

por Atas, Ali, Seddon, Alan M., Ford, Donna C., Cooper, Ian A., Wren, Brendan W., Oyston, Petra C. F., Karlyshev, Andrey V.
Publicado en BMC Microbiol (2016)